Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
presenilin 1 | 0.469 | 0.846 | 0.97 |
|
disease | 0.900 | None | 0.993 | 81 | 100 | 1995 | 2020 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 1.000 | None | 0.979 | 73 | 122 | 1989 | 2020 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 1.000 | None | 0.966 | 72 | 39 | 1970 | 2019 | ||||||||
|
transthyretin | 0.423 | 0.885 | 0.52 |
|
disease | 1.000 | None | 0.992 | 72 | 43 | 1983 | 2020 | ||||||||
|
gap junction protein beta 1 | 0.514 | 0.731 | 0.85 |
|
disease | 1.000 | None | 1.000 | 58 | 72 | 1993 | 2019 | ||||||||
|
cytochrome P450 family 21 subfamily A member 2 | 0.525 | 0.769 | 2.6E-04 |
|
disease | 0.800 | None | 0.976 | 54 | 36 | 1980 | 2020 | ||||||||
|
glucosylceramidase beta | 0.500 | 0.808 | 1.4E-06 |
|
disease | 1.000 | None | 0.984 | 48 | 95 | 1983 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 1 | 0.477 | 0.808 | 1.00 |
|
disease | 0.800 | None | 1.000 | 43 | 184 | 2000 | 2018 | ||||||||
|
spastin | 0.579 | 0.577 | 1.00 |
|
disease | 1.000 | None | 1.000 | 43 | 26 | 1991 | 2019 | ||||||||
|
leucine rich repeat kinase 2 | 0.510 | 0.808 | 2.6E-30 |
|
disease | 0.930 | None | 1.000 | 42 | 30 | 2004 | 2019 | ||||||||
|
arylsulfatase A | 0.448 | 0.923 | 1.1E-11 |
|
disease | 1.000 | None | 0.978 | 42 | 56 | 1975 | 2019 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.800 | None | 0.989 | 41 | 23 | 1984 | 2019 | ||||||||
|
potassium voltage-gated channel subfamily Q member 1 | 0.485 | 0.769 | 4.5E-08 |
|
disease | 1.000 | None | 0.990 | 41 | 196 | 1996 | 2019 | ||||||||
|
myelin protein zero | 0.503 | 0.846 | 0.27 |
|
disease | 1.000 | None | 1.000 | 39 | 30 | 1992 | 2019 | ||||||||
|
collagen type I alpha 1 chain | 0.430 | 0.808 | 1.00 |
|
disease | 0.890 | None | 1.000 | 37 | 61 | 1986 | 2019 | ||||||||
|
neurofibromin 1 | 0.440 | 0.885 | 0.90 |
|
disease | 1.000 | None | 0.976 | 33 | 72 | 1977 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 0.910 | None | 1.000 | 33 | 217 | 1995 | 2018 | ||||||||
|
sodium voltage-gated channel alpha subunit 1 | 0.477 | 0.808 | 1.00 |
|
disease | 0.730 | None | 1.000 | 31 | 33 | 2000 | 2012 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
disease | 0.900 | None | 0.981 | 30 | 11 | 1987 | 2020 | ||||||||
|
potassium voltage-gated channel subfamily H member 2 | 0.522 | 0.731 | 1.00 |
|
disease | 0.800 | None | 0.989 | 30 | 226 | 1995 | 2019 | ||||||||
|
parkin RBR E3 ubiquitin protein ligase | 0.431 | 0.846 | 6.9E-07 |
|
disease | 1.000 | None | 0.994 | 30 | 22 | 1998 | 2019 | ||||||||
|
protoporphyrinogen oxidase | 0.678 | 0.500 | 2.8E-02 |
|
disease | 0.900 | None | 1.000 | 30 | 18 | 1981 | 2019 | ||||||||
|
alkaline phosphatase, biomineralization associated | 0.546 | 0.769 | 3.6E-04 |
|
disease | 0.950 | None | 0.975 | 29 | 53 | 1988 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 1.000 | None | 1.000 | 29 | 141 | 1995 | 2018 | ||||||||
|
von Willebrand factor | 0.408 | 0.885 | 3.2E-25 |
|
disease | 1.000 | None | 0.974 | 29 | 35 | 1987 | 2020 |